RxDoctor Payments Data

Erin Moore, PA

Medical · Hendersonville, NCNPI 1306276803

Payments from drug & device makers

$3,633in general payments, 2019–2025

Across 119 payments — averaging $30.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Collegium Pharmaceutical, Inc.$541
  • Abbott$393
  • Medtronic$333
  • Boston Scientific$207
  • Vertos Medical, Inc.$123
  • plus $705 from 14 others

What the payments were for

  • Travel & lodging$150%
  • Food & beverage$3,618100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,633 in reported general payments places this provider in the 85th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$96,269
Medicare patients
538
Services billed
1,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl75$55,858
RelistorMethylnaltrexone Bromide17$46,159
Buprenorphine134$32,266
Xtampza ErOxycodone Myristate48$29,981
NucyntaTapentadol Hcl20$19,680
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen482$16,211
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen580$13,469
MovantikNaloxegol Oxalate22$9,635
OxycontinOxycodone Hcl32$8,741
LinzessLinaclotide15$7,561
Oxycodone Hcl365$6,344
Morphine Sulfate ErMorphine Sulfate199$5,245
ButransBuprenorphine20$4,967
Pregabalin298$4,435
Gabapentin286$4,335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta$541$105,519143 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$87$46,15917 claims
AbbVieLinzess$55$7,56115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 878 medical providers in North Carolina.

Other medical in Hendersonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →